Longitude Capital

New York
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance the quality of life, and/or reduce system costs. They invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multiple market cycles. Their venture growth strategy is rooted in building a balanced portfolio of clinical-stage and commercial-stage companies with clinically de-risked assets, favorable valuations relative to risk profile, and attractive expected returns within three to five years from the initial investment. Longitude Capital seeks to identify new investment opportunities by tapping into their broad network of industry relationships or through the execution of intensive thematic research into emerging therapeutic areas or industry sub-sectors. They utilize a variety of investment structures, including traditional venture capital, asset spin-outs, recapitalizations, PIPEs, open market purchases, royalties, and other equity and equity-linked instruments.
Founded:2006
Firm Location:New York • Alabama • Connecticut • New York, New York • San Francisco, California • Palo Alto, California • Menlo Park, California • Stanford, California • San Francisco Bay Area
Investor Firms That Co-Invest with Longitude Capital
Longitude Capital Team
Photo of Irvin Akinseye, Associate at Longitude Capital
Irvin Akinseye
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Photo of Maxwell Bikoff, Principal at Longitude Capital
Maxwell Bikoff
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Photo of Varun Gupta, Vice President at Longitude Capital
Varun Gupta
Longitude Capital·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Victoria Lai, Vice President at Longitude Capital
Victoria Lai
Longitude Capital·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Michelle Li, Associate at Longitude Capital
Michelle Li
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Brian Liu, Principal at Longitude Capital
Brian Liu
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Sonia Parekh, Associate at Longitude Capital
Sonia Parekh
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Menlo Park (CA)
Photo of Amar Patel, Senior Associate at Longitude Capital
Amar Patel
Longitude Capital·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Hyde Patterson, Associate at Longitude Capital
Hyde Patterson
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Josh Sherman, Vice President at Longitude Capital
Josh Sherman
Longitude Capital·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Juliet Tammenoms Bakker, Managing Director at Longitude Capital
Juliet Tammenoms Bakker
Longitude Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Photo of Michael Wert, Principal at Longitude Capital
Michael Wert
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Menlo Park (CA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)